Statistics
Publications
1
Citations
718
H-Index
1
Active since
2007
Affiliations
Dana-Farber Cancer Institute(Current)
Christopher-Michael Gale is an author at Dana-Farber Cancer Institute specializing in egfr inhibition, erlotinib therapy, and pharmacology.
Publications per year
2007–2007
1
1
Jeffrey A. Engelman, Kreshnik Zejnullahu, Christopher-Michael Gale et al. · Cancer Research · 2007 · 718 citations · Full text
Medicine, Oncology, Pharmacology +13
1–1 of 1